Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
180 participants
OBSERVATIONAL
2021-02-09
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Cervical Cancer Screening Among HIV-Infected Women in India
NCT02247999
Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India
NCT07290972
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
NCT05102240
A Pilot Study on HPV and Cervical Cancer Screening in Mumbai
NCT03229603
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NCT07209917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV Positive
Cervical Cancer Patients with HIV positive
Radiation Therapy
Standard of Care Chemoradiation for Cervical cancer patients in India.
HIV Negative
Cervical Cancer Patients with HIV negative
Radiation Therapy
Standard of Care Chemoradiation for Cervical cancer patients in India.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiation Therapy
Standard of Care Chemoradiation for Cervical cancer patients in India.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky performance status ≥ 70
* Patients with lower paraortic lymph nodes (below the level of L2 vertebra)
* patients diagnosed with cervical cancer whom also HIV positive or HIV negative
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tata Memorial Hospital
OTHER_GOV
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Surbhi Grover, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tata Memorial Hospital
Mumbai, Maharashtra, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
834664
Identifier Type: OTHER
Identifier Source: secondary_id
DAA3-19-65331-1
Identifier Type: OTHER
Identifier Source: secondary_id
UPCC 20824
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.